Graceway Pharmaceuticals, LLC
25
0
0
22
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
8.0%
2 terminated/withdrawn out of 25 trials
91.7%
+5.2% vs industry average
44%
11 trials in Phase 3/4
50%
11 of 22 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (25)
Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal
Role: collaborator
The Effects of Aldara as an Adjunct to Laser Treatment
Role: collaborator
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Role: collaborator
Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
Role: lead
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
Role: lead
Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
Role: collaborator
Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
Role: lead
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
Role: lead
Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream
Role: lead
Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
Role: lead
Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
Role: lead
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Role: lead
A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence
Role: lead
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
Role: lead
Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
Role: lead
A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy
Role: collaborator
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands
Role: lead
Study With a Topical Gel to Treat Common Warts in Adults
Role: lead
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Role: lead
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Role: lead